Loading...
Clinical CAR-T Cell and Oncolytic Virotherapy for Cancer Treatment
Immunotherapy has recently garnered success with the induction of clinical responses in tumors, which are traditionally associated with poor outcomes. Chimeric antigen receptor T (CAR-T) cells and oncolytic viruses (OVs) have emerged as promising cancer immunotherapy agents. Herein, we provide an ov...
Saved in:
| Published in: | Mol Ther |
|---|---|
| Main Authors: | , , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
American Society of Gene & Cell Therapy
2021
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7854303/ https://ncbi.nlm.nih.gov/pubmed/33130314 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ymthe.2020.10.023 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|